Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04588 secretin receptor, putative | Get druggable targets OG5_139196 | All targets in OG5_139196 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0204 | 0.3668 | 1 |
Brugia malayi | RNA binding protein | 0.0204 | 0.3668 | 0.3668 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0288 | 0.0382 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.0412 | 0.1124 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.0037 | 0.0074 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0288 | 0.0785 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0288 | 0.0785 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0115 | 0.1738 | 0.1738 |
Echinococcus granulosus | transcription factor btf3 | 0.0037 | 0.0074 | 0.0098 |
Schistosoma mansoni | transcription factor btf3 | 0.0037 | 0.0074 | 0.0202 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0288 | 0.0382 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0384 | 0.7532 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0204 | 0.3668 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.0288 | 0.0288 |
Onchocerca volvulus | 0.0034 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0498 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0074 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0053 | 0.0412 | 0.0548 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0053 | 0.0412 | 0.0548 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.1738 | 0.1738 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0288 | 0.0382 |
Loa Loa (eye worm) | RNA binding protein | 0.0204 | 0.3668 | 0.3668 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0168 | 0.288 | 0.288 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0053 | 0.0412 | 0.0412 |
Schistosoma mansoni | tar DNA-binding protein | 0.0204 | 0.3668 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0288 | 0.0382 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.0412 | 0.1124 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0288 | 0.0785 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0053 | 0.0412 | 0.0412 |
Plasmodium falciparum | basic transcription factor 3b, putative | 0.0037 | 0.0074 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0034 | 0 | 0.5 |
Toxoplasma gondii | NAC domain-containing protein | 0.0037 | 0.0074 | 0.5 |
Entamoeba histolytica | transcription factor BTF3, putative | 0.0037 | 0.0074 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0034 | 0 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0204 | 0.3668 | 0.487 |
Brugia malayi | beta-NAC-like protein | 0.0037 | 0.0074 | 0.0074 |
Echinococcus multilocularis | transcription factor btf3 | 0.0037 | 0.0074 | 0.0098 |
Schistosoma mansoni | tar DNA-binding protein | 0.0204 | 0.3668 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0053 | 0.0412 | 0.0412 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0034 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.0412 | 0.1124 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0168 | 0.288 | 0.288 |
Schistosoma mansoni | hypothetical protein | 0.0115 | 0.1738 | 0.4739 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0204 | 0.3668 | 0.3668 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0412 | 0.0412 |
Trypanosoma brucei | transcription factor BTF3, putative | 0.0037 | 0.0074 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0204 | 0.3668 | 0.487 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0053 | 0.0412 | 0.0548 |
Echinococcus granulosus | GPCR family 2 | 0.0053 | 0.0412 | 0.0548 |
Leishmania major | basic transcription factor 3a, putative | 0.0037 | 0.0074 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.0074 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.0412 | 0.1124 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.0074 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0204 | 0.3668 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0204 | 0.3668 | 0.3668 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.0037 | 0.0074 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0204 | 0.3668 | 0.3668 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.0288 | 0.0288 |
Loa Loa (eye worm) | ICD-1 protein | 0.0037 | 0.0074 | 0.0074 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.0074 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0204 | 0.3668 | 0.3668 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0384 | 0.7532 | 1 |
Plasmodium vivax | basic transcription factor 3b, putative | 0.0037 | 0.0074 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 59.613 uM | PUBCHEM_BIOASSAY: Luminescence-based cell-based high throughput dose response assay for activators of the GAA850 frataxin (FXN) promoter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540364, AID588328, AID588350, AID588351] | ChEMBL. | No reference |
EC50 (functional) | > 59.613 uM | PUBCHEM_BIOASSAY: Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput dose response assay to identify activators of the GAA30 frataxin promoter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540364, AID588328, AID588350, AID588351] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.